Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVOW
Q4 2025 vs. Q3 2025
How the institutions holding Alvotech changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 49 | −16 |
| Shares | 15.8M | 181.6K | 15.6M | −88.1K (−0.6%) |
| Value | $127.9M | $4.89K | $78.1M | −$49.8M (−38.9%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Alvotech at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 92,314 | $473.6K | 0.00% |
| Stifel Financial Corp | 20,995 | $107.7K | 0.00% |
| Point72 Asset Management, L.P. | 14,840 | $76.1K | 0.00% |
| Aquatic Capital Management LLC | 4,571 | $23.4K | 0.00% |
| Smartleaf Asset Management LLC | 162 | $818 | 0.00% |
Sold out (21)
Institutions that held Alvotech at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Marshall Wace, LLP | 136,859 | $1.12M |
| Royce & Associates LP | 124,346 | $1.02M |
| Northern Trust Corp | 95,890 | $785.3K |
| Citadel Advisors LLC | 42,202 | $345.6K |
| LPL Financial LLC | 41,238 | $337.7K |
| TBH Global Asset Management, LLC | 35,500 | $290.7K |
| XTX Topco Ltd | 27,246 | $223.1K |
| Wolverine Asset Management LLC | 23,065 | $188.9K |
| Quadrature Capital Ltd | 22,729 | $185.9K |
| GWN Securities Inc. | 19,591 | $160.5K |
| Mariner, LLC | 10,768 | $88.2K |
| Magnetar Financial LLC | 10,462 | $85.7K |
| State of Wyoming | 6,606 | $54.1K |
| Wells Fargo & Company | 6,400 | $52.4K |
| Steward Partners Investment Advisory, LLC | 1,715 | $14.0K |
| Jones Financial Companies LLLP | 451 | $3.76K |
| Farther Finance Advisors, LLC | 273 | $2.24K |
| GAMMA Investing LLC | 225 | $1.84K |
| EverSource Wealth Advisors, LLC | 134 | $1.10K |
| SWAN Capital LLC | 100 | $819 |
| Bare Financial Services, Inc | 62 | $508 |
Not filed for Q4 2025 yet (1)
Institutions that held Alvotech at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Lodbrok Capital LLP | 181,587 | $4.89K |